The Prognostic Significance of the Concentration of Nimodipine in the CSF and Plasma in Subarachnoid Hemorrhage

  • W. I. Steudel
  • M. Carvi
  • S. Tiyaworabun
  • R. Lorenz
Conference paper
Part of the Advances in Neurosurgery book series (NEURO, volume 18)

Abstract

A major cause of mortality and morbidity in subarachnoid hemorrhage of aneurysmal origin is vasospasm. An analysis of the available placebo-controlled double-blind and open prospective studies provides statistically significant evidence that the calcium antagonist nimodipine can reduce the frequency of these spasm-induced delayed ischemic neurological deficits. However, very divergent percentages are reported in the various studies, ranging in the randomized studies from 1% with intravenous administration to 2%–16% with oral dosage [1–6,8–11]. It is unclear what intraindividual and interindividual variations in the plasma and CSF concentration are present or are to be expected in medication with nimodipine. A high level of protein binding and the interaction with other drugs are known with regard to pharmacokinetics [12].

Keywords

Starch Albumin Dexamethasone Neurol Hunt 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allen GS, Hyo SA, Preziosi TJ et al. (1983) Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid haemorrhage. N Engl J Med 308:619–624PubMedCrossRefGoogle Scholar
  2. 2.
    Auer LM (1984) Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms. Neurosurgery 15:57–66PubMedCrossRefGoogle Scholar
  3. 3.
    Auer LM, Brandt L, Ebeling U et al. (1986) Nimodipine and early aneurysm operation for good condition SAH patients. Acta Neurochir (Wien) 82:7–13CrossRefGoogle Scholar
  4. 4.
    Auer LM, Schneider GH, Auer T (1986) Computerized tomography and prognosis in early aneurysm surgery. J Neurosurg 65:217–221PubMedCrossRefGoogle Scholar
  5. 5.
    Gilsbach J (1988) Nimodipine in the prevention of ischaemic deficits after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) [Suppl] 54:41–50Google Scholar
  6. 6.
    Grotenhuis JA, Bettag W (1986) Prevention of symptomatic vasospasm after SAH by constant venous infusion of nimodipine. Neurol Res 8:243–248PubMedGoogle Scholar
  7. 7.
    Härders A, Gilsbach J (1988) Haemodynamic effectiveness of nimodipine on spastic brain vessels after subarachnoid haemorrhage evaluated by the transcranial Doppler method. Acta Neurochir (Wien) 45:21–28Google Scholar
  8. 8.
    Kazner E, Sprung C, Adelt D et al. (1985) Clinical experience with nimodipine in the prophylaxis of neurological deficits after subarachnoid haemorrhage. Neurochirurgia 18:110–113Google Scholar
  9. 9.
    Neil-Dwyer G, Mee E, Dorrance D, Lowe D (1987) Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J 8:41–47PubMedGoogle Scholar
  10. 10.
    Öhman J, Heiskanen O (1987) The effect of nimodipine on cerebrovascular spasm after subarachnoid haemorrhage — a randomized, double-blind study, presented at the 2nd World Congress of Neuroscience, Budapest, Hungary, August 16–21, 1987Google Scholar
  11. 11.
    Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P (1986) Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir (Wien) 82:110–114CrossRefGoogle Scholar
  12. 12.
    Raemsch KH, Graefe KH, Sommer J (1985) Pharmacokinetics and metabolism of nimodipine. In: Betz E, Deck K, Hoffmeister F (eds) Nimodipine, pharmacological and clinical properties. Schattauer, Stuttgart, pp 147–159Google Scholar
  13. 13.
    Scriabine A, Battye R, Hoffmeister F et al. (1985) Nimodipine. In: Scriabine A (ed) New drugs annual: cardiovascular drugs, vol 3. Raven, New York, pp 197–218Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • W. I. Steudel
  • M. Carvi
  • S. Tiyaworabun
  • R. Lorenz
    • 1
  1. 1.Abteilung für Allgemeine NeurochirurgieJohann Wolfgang Goethe-UniversitätFrankfurt 71Germany

Personalised recommendations